Patients with temporal lobe epilepsy show an increase in brain-derived neurotrophic factor protein and its correlation with neuropeptide Y

Brain Research

Volumn 818, Issue 2, 1999, Pages 579-582

  Takahashi, Makoto ^a,b   Hayashi, Shintaro ^a   Kakita, Akiyoshi ^a   Wakabayashi, Koichi ^a   Fukuda, Masafumi ^c   Kameyama, Shigeki ^c   Tanaka, Ryuichi ^a   Takahashi, Hitoshi ^a   Nawa, Hiroyuki ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c NISHI NIIGATA CHUO NATIONAL HOSPITAL   (Japan)

Author keywords

Brain derived neurotrophic factor; Epilepsy; Human; Nerve growth factor; Neuropeptide Y; Neurotrophin 3

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROPEPTIDE Y;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; TEMPORAL LOBE EPILEPSY;

ADOLESCENT; ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; EPILEPSY, TEMPORAL LOBE; FEMALE; HUMANS; MALE; NERVE GROWTH FACTORS; NEUROPEPTIDE Y; NEUROTROPHIN 3;

EID: 0033550702     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01355-9     Document Type: Article

References (23)

1. Adams B., Sazgar M., Osehobo P., Van der Zee C.E., Diamond J., Fahnestock M., Racine R.J. Nerve growth factor accelerates seizure development, enhances mossy fiber sprouting, and attenuates seizure-induced decreases in neuronal density in the kindling model of epilepsy. J. Neurosci. 17:1997;5288-5296.
2. Bellmann R., Widmann R., Olenik C., Meyer D.K., Maas D., Marksteiner J., Sperk G. Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid-induced seizures. J. Neurochem. 56:1991;525-530.
3. Bengzon J., Soderstrom S., Kokaia Z., Kokaia M., Ernfors P., Persson H., Ebendal T., Lindvall O. Widespread increase of nerve growth factor protein in the rat forebrain after kindling-induced seizures. Brain Res. 587:1992;338-342.
4. Bessho Y., Nakanishi S., Nawa H. Glutamate receptor agonists enhance the expression of BDNF mRNA in cultured cerebellar granule cells. Mol. Brain Res. 18:1993;201-208.
5. Croll S.D., Wiegand S.J., Anderson K.D., Lindsay R.M., Nawa H. Regulation of neuropeptides in adult rat forebrain by the neurotrophins BDNF and NGF. Eur. J. Neurosci. 6:1994;1343-1353.
6. Dugich-Djordjevic M.M., Tocco G., Willoughby D.A., Najm I., Pasinetti G., Thompson R.F., Baudry M., Lapchak P.A., Hefti F. BDNF mRNA expression in the developing rat brain following kainic acid induced seizure activity. Neuron. 8:1992;1127-1138.
7. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:1996;415-418.
8. Ernfors P., Bengzon J., Kokaia Z., Persson H., Lindvall O. Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron. 7:1991;165-176.
9. Gall C.M., Isackson P.J. Limbic seizures increase neuronal production of messenger RNA for nerve growth factor. Science. 245:1989;758-761.
10. Holtzman D.M., Lowenstein D.H. Selective inhibition of axon outgrowth by antibodies to NGF in a model of temporal lobe epilepsy. J. Neurosci. 15:1995;7062-7070.
11. Isackson P.J., Huntsman M.M., Murray K.D., Gall C.M. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. Neuron. 6:1991;937-948.
12. Kokaia M., Ernfors P., Kokaia Z., Elmer E., Jaenisch R., Lindvall O. Suppressed epileptogenesis in BDNF mutant mice. Exp. Neurol. 133:1995;215-224.
13. Larmet Y., Reibel S., Carnahan J., Nawa H., Marescaux C., Depaulis A. Protective effects of brain-derived neurotrophic factor on the development of hippocampal kindling in the rat. Neuroreport. 6:1995;1937-1941.
14. Lewin G.R., Barde Y.A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19:1996;289-317.
15. Marty S., Berninger B., Carroll P., Thoenen H. GABAergic stimulation regulates the phenotype of hippocampal interneurons through the regulation of brain-derived neurotrophic factor. Neuron. 16:1996;565-570.
16. Mathern G.W., Babb T.L., Pretorius J.K., Leite J.P. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J. Neurosci. 15:1995;3990-4004.
17. Mathern G.W., Babb T.L., Micevych P.E., Blanco C.E., Pretorius J.K. Granule cell mRNA levels for BDNF, NGF, and NT-3 correlate with neuron losses or supragranular mossy fiber sprouting in the chronically damaged and epileptic human hippocampus. Mol. Chem. Neuropathol. 30:1997;53-76.
18. Narisawa S.M., Wakabayashi K., Tsuji S., Takahashi H., Nawa H. Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. Neuroreport. 7:1996;2925-2928.
19. Nawa H., Bessho Y., Carnahan J., Nakanishi S., Mizuno K. Regulation of neuropeptide expression in cultured cerebral cortical neurons by brain-derived neurotrophic factor. J. Neurochem. 60:1993;772-775.
20. Nawa H., Carnahan J., Gall C. BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: partial disagreement with mRNA levels. Eur. J. Neurosci. 7:1995;1527-1535.
21. Strowbridge B.W., Bean A.J., Spencer D.D., Roth R.H., Shepherd G.M., Robbins R.J. Low levels of somatostatin-like immunoreactivity in neocortex resected from presumed seizure foci in epileptic patients. Brain Res. 587:1992;164-168.
22. Woldbye D.P., Larsen P.J., Mikkelsen J.D., Klemp K., Madsen T.M., Bolwig T.G. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nat. Med. 3:1997;761-764.
23. Zafra F., Hengerer B., Leibrock J., Thoenen H., Lindholm D. Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors. EMBO J. 9:1990;3545-3550.